Today’s top gainers include the company Mylan N.V. (NASDAQ:MYL) which is in the industry Drugs – Generic, gaining -1.08% today. In the last week its performance is 4.19%, and -1.52% for the past quarter. Currently, Mylan N.V., MYL has a target price of 58.13, so today’s gain of -1.08% is a significant step towards its target price. The GAP today is therefore -0.38%.
Mylan N.V. (NASDAQ:MYL), has a market cap of 23957.78, and is based in USA. Insider ownership is at 0.70%, and institutional ownership is 70.90%.
At the current price of 46.69, it has a dividend yield of *TBA, and its target price is 58.13. This is with a profit margin of 8.30%, and total debt/equity of 0.73. Mylan N.V. (NASDAQ:MYL) has a P/E of 30.18, as well as a forward P/E of 8.05.
With a current EPS of 1.56, and a forecasted EPS growth for next year at 18.48%,Mylan N.V. (NASDAQ:MYL) has had a EPS growth for the past five years at 20.20%. For the next five years EPS growth is projected to be 13.98%.
Performance for the year is -29.77%. Since its IPO date on 12/18/1987, the total performance to date is -12.71%.
Volume today for Mylan N.V. (NASDAQ:MYL), is 3331955, while its average volume is 4962.37. Whilst the total gain today was -1.08%, it did have a day high of -1.10%.
Volatility for this week has been at 2.30%, and 2.58% for the month. The 52-week low for Mylan N.V., MYL has been 24.21%, while the 52-week-high has reached -31.43%.
Looking at its return of investments, which is 8.20%, and its return on assets is 3.60%. Mylan N.V. (NASDAQ:MYL) has an operating margin of 14.60%. With a sales growth of 17.10% quarter over quarter. Bearing in mind that Mylan N.V., MYL is in the sector Healthcare, its long-term debt/equity is 0.62, and has a current ratio of 1.7 and 1.1 for quick ratio.
So what is the value of Mylan N.V.? Well its PEG is 2.16, and the P/S is 2.46, along with a P/B of 2.25. Meanwhile it has a p/cash of 19.97.